Lv1
24 积分 2026-10-13 加入
Burden of chronic respiratory disease in Asia, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
1天前
已完结
Biological therapy for chronic obstructive pulmonary disease (COPD): Effectiveness and safety
1天前
已完结
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials
1天前
已完结
皖公网安备34019202002308
